Rchr
J-GLOBAL ID:202201015234826075   Update date: Aug. 22, 2024

Kawasuji Hitoshi

カワスジ ヒトシ | Kawasuji Hitoshi
Affiliation and department:
Research theme for competitive and other funds  (12):
  • 2024 - 2026 口腔細菌由来プロテアーゼからのCOVID-19病態解明~新規重症化制御法への展開
  • 2023 - 2026 COVID-19モデルでの濾胞性ヘルパーT細胞による免疫応答修飾機構の解明
  • 2022 - 2024 COVID-19重症化を予防する中和活性レベルの特定とワクチン接種計画への展開
  • 2023 - 2024 腸内細菌叢を基盤とした薬剤耐性菌定着リスクスクリーニングに関する研究
  • 2023 - 2024 唾液中薬物濃度モニタリング(STDM)の確立による抗微生物薬個別化投与の新展開
Show all
Papers (47):
  • Kotaro Mitsutake, Natsuki Shinya, Masafumi Seki, Takahiro Ohara, Kohei Uemura, Masato Fukunaga, Jun Sakai, Miki Nagao, Makoto Sata, Yohei Hamada, et al. Antimicrobial therapy and outcome of methicillin-resistant Staphylococcus aureus endocarditis: A retrospective multicenter study in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024. 30. 9. 860-866
  • Kotaro Mitsutake, Natsuki Shinya, Masafumi Seki, Takahiro Ohara, Kohei Uemura, Masato Fukunaga, Jun Sakai, Miki Nagao, Makoto Sata, Yohei Hamada, et al. Clinical characteristics and analysis of prognostic factors in methicillin-resistant Staphylococcus aureus endocarditis: A retrospective multicenter study in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024
  • Kentaro Nagaoka, Naoki Iwanaga, Yushi Murai, Hitoshi Kawasuji, Masayoshi Miura, Yukihiro Sato, Hiroyuki Ito, Yasushi Terasaki, Takahiro Takazono, Kosuke Kosai, et al. Clinical phenotype of anaerobic bacteremia unaccompanied by detectable abscess lesion: a 10-year retrospective, multicenter, observational-cohort study. Infection. 2024
  • Hitoshi Kawasuji, Yoshitomo Morinaga, Kentaro Nagaoka, Hideki Tani, Yoshihiro Yoshida, Hiroshi Yamada, Yusuke Takegoshi, Makito Kaneda, Yushi Murai, Kou Kimoto, et al. High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection. Frontiers in Immunology. 2024. 15
  • Kentaro Nagaoka, N Iwanaga, Y Takegoshi, Y Murai, H Kawasuji, M Miura, Y Sato, Y Hatakeyama, H Ito, Y Kato, et al. Mortality risk factors and fulminant sub-phenotype in anaerobic bacteremia: a 10-year retrospective, multicenter, observational cohort study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2024. 43. 3. 459-467
more...
MISC (1):
  • 喜多俊介, 安楽佑樹, 小澤龍彦, 谷英樹, 五十嵐笑子, 佐賀由美子, 稲崎倫子, 川筋仁史, 山田博司, 佐々木宗一郎, et al. 新型コロナウイルスに対するスーパー中和抗体UT28Kの分子基盤. 日本結晶学会年会講演要旨集. 2022. 2022
Awards (11):
  • 2024 - 公益財団法人富山第一銀行奨学財団賞 奨励賞
  • 2024 - 第98回日本感染症学会学術講演会・第72回日本化学療法学会総会合同学会 若手最優秀演題賞
  • 2023 - 第6回(令和5年度)日本感染症学会臨床研究促進助成
  • 2023 - 第8回(2023年)日本化学療法学会上原感染症・化学療法研究奨励賞
  • 2022 - 第24回 2022年度 日本感染症医薬品協会奨励賞
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page